1. Home
  2. PTCT vs TFSL Comparison

PTCT vs TFSL Comparison

Compare PTCT & TFSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTCT
  • TFSL
  • Stock Information
  • Founded
  • PTCT 1998
  • TFSL 1938
  • Country
  • PTCT United States
  • TFSL United States
  • Employees
  • PTCT N/A
  • TFSL N/A
  • Industry
  • PTCT Biotechnology: Pharmaceutical Preparations
  • TFSL Savings Institutions
  • Sector
  • PTCT Health Care
  • TFSL Finance
  • Exchange
  • PTCT Nasdaq
  • TFSL Nasdaq
  • Market Cap
  • PTCT 5.3B
  • TFSL 3.9B
  • IPO Year
  • PTCT 2013
  • TFSL 2007
  • Fundamental
  • Price
  • PTCT $74.73
  • TFSL $13.85
  • Analyst Decision
  • PTCT Buy
  • TFSL Hold
  • Analyst Count
  • PTCT 17
  • TFSL 1
  • Target Price
  • PTCT $73.24
  • TFSL $15.00
  • AVG Volume (30 Days)
  • PTCT 1.1M
  • TFSL 429.7K
  • Earning Date
  • PTCT 11-04-2025
  • TFSL 10-30-2025
  • Dividend Yield
  • PTCT N/A
  • TFSL 8.15%
  • EPS Growth
  • PTCT N/A
  • TFSL 14.29
  • EPS
  • PTCT 8.94
  • TFSL 0.32
  • Revenue
  • PTCT $1,779,150,000.00
  • TFSL $318,974,000.00
  • Revenue This Year
  • PTCT $119.02
  • TFSL $10.29
  • Revenue Next Year
  • PTCT N/A
  • TFSL $3.28
  • P/E Ratio
  • PTCT $8.37
  • TFSL $43.31
  • Revenue Growth
  • PTCT 97.54
  • TFSL 4.70
  • 52 Week Low
  • PTCT $35.95
  • TFSL $11.29
  • 52 Week High
  • PTCT $75.00
  • TFSL $15.00
  • Technical
  • Relative Strength Index (RSI)
  • PTCT 78.02
  • TFSL 56.38
  • Support Level
  • PTCT $69.23
  • TFSL $13.50
  • Resistance Level
  • PTCT $73.98
  • TFSL $13.80
  • Average True Range (ATR)
  • PTCT 2.64
  • TFSL 0.30
  • MACD
  • PTCT 0.35
  • TFSL 0.04
  • Stochastic Oscillator
  • PTCT 98.01
  • TFSL 74.85

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.

About TFSL TFS Financial Corporation

TFS Financial Corp is the holding company for the Third Federal Savings and Loan Association of Cleveland. The company's ownership in the savings and loan association is its primary business activity. The association's principal business consists of originating and servicing residential real estate mortgage loans and attracting retail savings deposits. It does so by offering products with competitive rates and yields. The company also operates Third Capital, a wholly owned subsidiary that serves as a holding company or as an investor in vehicles such as private equity funds. Third Capital has interests in lease transactions of commercial buildings, title agencies providing escrow and settlement services, and reinsurance of private mortgage insurance on residential loans.

Share on Social Networks: